Efficacy and safety of the metformin-mazindol anorectic combination in rat

The current study investigates the anorectic interaction and safety of the mazindol-metformin combination in rats. Isobologram and interaction index were used to determine anorectic interaction between mazindol and metformin in the sweetened milk model. The safety profile of the mazindol-metformin c...

Full description

Saved in:
Bibliographic Details
Main Authors: Argüelles-Tello Federico, Roa-Coria José Eduardo, Zúñiga-Romero Ángel, Huerta-Cruz Juan Carlos, Quiñonez-Bastidas Geovanna Nalley, Flores-Murrieta Francisco Javier, Rocha-González Héctor Isaac, Reyes-García Juan Gerardo
Format: Article
Language:English
Published: Sciendo 2021-06-01
Series:Acta Pharmaceutica
Subjects:
Online Access:https://doi.org/10.2478/acph-2021-0019
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832570297657589760
author Argüelles-Tello Federico
Roa-Coria José Eduardo
Zúñiga-Romero Ángel
Huerta-Cruz Juan Carlos
Quiñonez-Bastidas Geovanna Nalley
Flores-Murrieta Francisco Javier
Rocha-González Héctor Isaac
Reyes-García Juan Gerardo
author_facet Argüelles-Tello Federico
Roa-Coria José Eduardo
Zúñiga-Romero Ángel
Huerta-Cruz Juan Carlos
Quiñonez-Bastidas Geovanna Nalley
Flores-Murrieta Francisco Javier
Rocha-González Héctor Isaac
Reyes-García Juan Gerardo
author_sort Argüelles-Tello Federico
collection DOAJ
description The current study investigates the anorectic interaction and safety of the mazindol-metformin combination in rats. Isobologram and interaction index were used to determine anorectic interaction between mazindol and metformin in the sweetened milk model. The safety profile of the mazindol-metformin combination was determined by measuring anxiety, blood pressure, hematic biometry and blood chemistry. An acute dose of mazindol and metformin administered per os, individually or as a mixture, has reduced the milk consumption in rats in a dose-dependent manner. Theoretical effective dose 40 (ED40t) did not differ from the experimental effective dose 40 (ED40e) obtained with the mazindol-metformin mixture in the anorexia experiments, by Student′s t-test. In addition, the interaction index confirmed the additive anorectic effect between both drugs. A single oral dose of ED40e mazindol-metformin mixture induced anxiolysis in the elevated plus-maze test. Moreover, oral administration of mazindol-metformin combination for 3 months significantly decreased glycemia, but not blood pressure nor other parameters of hematic biometry and blood chemistry. Results suggest that mazindol-metformin combination exerts an additive anorectic effect, as well as anxiolytic and hypoglycemic properties. Mazindol-metformin combination might be useful in obese patients with anxiety disorders or diabetes risk factors.
format Article
id doaj-art-442158c5f19e4e5da26053a3280b6b02
institution Kabale University
issn 1846-9558
language English
publishDate 2021-06-01
publisher Sciendo
record_format Article
series Acta Pharmaceutica
spelling doaj-art-442158c5f19e4e5da26053a3280b6b022025-02-02T15:49:11ZengSciendoActa Pharmaceutica1846-95582021-06-0171227929110.2478/acph-2021-0019acph-2021-0019Efficacy and safety of the metformin-mazindol anorectic combination in ratArgüelles-Tello Federico0Roa-Coria José Eduardo1Zúñiga-Romero Ángel2Huerta-Cruz Juan Carlos3Quiñonez-Bastidas Geovanna Nalley4Flores-Murrieta Francisco Javier5Rocha-González Héctor Isaac6Reyes-García Juan Gerardo7Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional Plan de San Luis y Díaz Mirón s/n Col. Casco de Santo Tomas, Miguel Hidalgo, 11340, Ciudad de México, MéxicoSección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional Plan de San Luis y Díaz Mirón s/n Col. Casco de Santo Tomas, Miguel Hidalgo, 11340, Ciudad de México, MéxicoSección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional Plan de San Luis y Díaz Mirón s/n Col. Casco de Santo Tomas, Miguel Hidalgo, 11340, Ciudad de México, MéxicoUnidad de Investigación en Farmacología Instituto Nacional de Enfermedades Respiratorias, Ismael Cosio Villegas Secretaría de Salud, Calzada de Tlalpan 4502, Col. Belisario Domínguez Sección XVI, Tlalpan, 14080, Ciudad de México MéxicoSección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional Plan de San Luis y Díaz Mirón s/n Col. Casco de Santo Tomas, Miguel Hidalgo, 11340, Ciudad de México, MéxicoSección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional Plan de San Luis y Díaz Mirón s/n Col. Casco de Santo Tomas, Miguel Hidalgo, 11340, Ciudad de México, MéxicoSección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional Plan de San Luis y Díaz Mirón s/n Col. Casco de Santo Tomas, Miguel Hidalgo, 11340, Ciudad de México, MéxicoSección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional Plan de San Luis y Díaz Mirón s/n Col. Casco de Santo Tomas, Miguel Hidalgo, 11340, Ciudad de México, MéxicoThe current study investigates the anorectic interaction and safety of the mazindol-metformin combination in rats. Isobologram and interaction index were used to determine anorectic interaction between mazindol and metformin in the sweetened milk model. The safety profile of the mazindol-metformin combination was determined by measuring anxiety, blood pressure, hematic biometry and blood chemistry. An acute dose of mazindol and metformin administered per os, individually or as a mixture, has reduced the milk consumption in rats in a dose-dependent manner. Theoretical effective dose 40 (ED40t) did not differ from the experimental effective dose 40 (ED40e) obtained with the mazindol-metformin mixture in the anorexia experiments, by Student′s t-test. In addition, the interaction index confirmed the additive anorectic effect between both drugs. A single oral dose of ED40e mazindol-metformin mixture induced anxiolysis in the elevated plus-maze test. Moreover, oral administration of mazindol-metformin combination for 3 months significantly decreased glycemia, but not blood pressure nor other parameters of hematic biometry and blood chemistry. Results suggest that mazindol-metformin combination exerts an additive anorectic effect, as well as anxiolytic and hypoglycemic properties. Mazindol-metformin combination might be useful in obese patients with anxiety disorders or diabetes risk factors.https://doi.org/10.2478/acph-2021-0019mazindol-metformin combinationanorectic interactionanxiolysishypoglycemic effect
spellingShingle Argüelles-Tello Federico
Roa-Coria José Eduardo
Zúñiga-Romero Ángel
Huerta-Cruz Juan Carlos
Quiñonez-Bastidas Geovanna Nalley
Flores-Murrieta Francisco Javier
Rocha-González Héctor Isaac
Reyes-García Juan Gerardo
Efficacy and safety of the metformin-mazindol anorectic combination in rat
Acta Pharmaceutica
mazindol-metformin combination
anorectic interaction
anxiolysis
hypoglycemic effect
title Efficacy and safety of the metformin-mazindol anorectic combination in rat
title_full Efficacy and safety of the metformin-mazindol anorectic combination in rat
title_fullStr Efficacy and safety of the metformin-mazindol anorectic combination in rat
title_full_unstemmed Efficacy and safety of the metformin-mazindol anorectic combination in rat
title_short Efficacy and safety of the metformin-mazindol anorectic combination in rat
title_sort efficacy and safety of the metformin mazindol anorectic combination in rat
topic mazindol-metformin combination
anorectic interaction
anxiolysis
hypoglycemic effect
url https://doi.org/10.2478/acph-2021-0019
work_keys_str_mv AT arguellestellofederico efficacyandsafetyofthemetforminmazindolanorecticcombinationinrat
AT roacoriajoseeduardo efficacyandsafetyofthemetforminmazindolanorecticcombinationinrat
AT zunigaromeroangel efficacyandsafetyofthemetforminmazindolanorecticcombinationinrat
AT huertacruzjuancarlos efficacyandsafetyofthemetforminmazindolanorecticcombinationinrat
AT quinonezbastidasgeovannanalley efficacyandsafetyofthemetforminmazindolanorecticcombinationinrat
AT floresmurrietafranciscojavier efficacyandsafetyofthemetforminmazindolanorecticcombinationinrat
AT rochagonzalezhectorisaac efficacyandsafetyofthemetforminmazindolanorecticcombinationinrat
AT reyesgarciajuangerardo efficacyandsafetyofthemetforminmazindolanorecticcombinationinrat